Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1992 Jun;67(6):482–485. doi: 10.1136/hrt.67.6.482

Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function.

J Nolan 1, A D Flapan 1, S Capewell 1, T M MacDonald 1, J M Neilson 1, D J Ewing 1
PMCID: PMC1024892  PMID: 1622699

Abstract

BACKGROUND--Activation of the sympathetic nervous system has been extensively studied in patients with chronic heart failure, but the parasympathetic nervous system has received relatively little attention. The objective in this study was to investigate cardiac parasympathetic activity in chronic heart failure and to explore its relation to left ventricular function. METHODS--Heart rate variability was measured from 24 hour ambulatory electrocardiograms by counting the number of times each RR interval exceeded the preceding RR interval by more than 50 ms (counts). This method provided a sensitive index of cardiac parasympathetic activity. RESULTS--Mean (range) of counts were: waking 48 (1-275)/h, sleeping 62 (0-360)/h, and total 1310 (31-7278)/24 h. These were lower than expected, and in 26 (60%) of the 43 patients counts fell below the lower 95% confidence intervals (95% CI) for RR counts in normal subjects. A significant correlation between total 24 hour RR counts and left ventricular ejection fraction was present (r = 0.49, p less than 0.05). CONCLUSIONS--These results indicate that most patients with chronic heart failure have reduced heart rate variability and therefore reduced cardiac parasympathetic activity. The degree of parasympathetic dysfunction is related to the severity of left ventricular dysfunction. This may be relevant to the high incidence of ventricular arrhythmias and poor prognosis of patients with chronic heart failure.

Full text

PDF
482

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akselrod S., Gordon D., Ubel F. A., Shannon D. C., Berger A. C., Cohen R. J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science. 1981 Jul 10;213(4504):220–222. doi: 10.1126/science.6166045. [DOI] [PubMed] [Google Scholar]
  2. Bellavere F., Ewing D. J. Autonomic control of the immediate heart rate response to lying down. Clin Sci (Lond) 1982 Jan;62(1):57–64. doi: 10.1042/cs0620057. [DOI] [PubMed] [Google Scholar]
  3. Casolo G., Balli E., Taddei T., Amuhasi J., Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol. 1989 Nov 15;64(18):1162–1167. doi: 10.1016/0002-9149(89)90871-0. [DOI] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., Findlay I. N., Wilson J. T. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. Br Heart J. 1987 May;57(5):436–445. doi: 10.1136/hrt.57.5.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cody R. J., Franklin K. W., Kluger J., Laragh J. H. Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition. Circulation. 1982 Jul;66(1):135–142. doi: 10.1161/01.cir.66.1.135. [DOI] [PubMed] [Google Scholar]
  7. De Jonge A., Knape J. T., Van Meel J. C., Kalkman H. O., Wilffert B., Thoolen M. J., Van Brummelen P., Timmermans P. B., Van Zwieten P. A. Effect of captopril on sympathetic neurotransmission in pithed normotensive rats. Eur J Pharmacol. 1983 Mar 25;88(2-3):231–240. doi: 10.1016/0014-2999(83)90010-9. [DOI] [PubMed] [Google Scholar]
  8. Dzau V. J., Colucci W. S., Hollenberg N. K., Williams G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981 Mar;63(3):645–651. doi: 10.1161/01.cir.63.3.645. [DOI] [PubMed] [Google Scholar]
  9. Dzau V. J., Hollenberg N. K., Williams G. H. Neurohumoral mechanisms in heart failure: role in pathogenesis, therapy, and drug tolerance. Fed Proc. 1983 Dec;42(15):3162–3169. [PubMed] [Google Scholar]
  10. Eckberg D. L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med. 1971 Oct 14;285(16):877–883. doi: 10.1056/NEJM197110142851602. [DOI] [PubMed] [Google Scholar]
  11. Eckberg D. L. Human sinus arrhythmia as an index of vagal cardiac outflow. J Appl Physiol Respir Environ Exerc Physiol. 1983 Apr;54(4):961–966. doi: 10.1152/jappl.1983.54.4.961. [DOI] [PubMed] [Google Scholar]
  12. Eckberg D. L. Parasympathetic cardiovascular control in human disease: a critical review of methods and results. Am J Physiol. 1980 Nov;239(5):H581–H593. doi: 10.1152/ajpheart.1980.239.5.H581. [DOI] [PubMed] [Google Scholar]
  13. Ewing D. J., Hume L., Campbell I. W., Murray A., Neilson J. M., Clarke B. F. Autonomic mechanisms in the initial heart rate response to standing. J Appl Physiol Respir Environ Exerc Physiol. 1980 Nov;49(5):809–814. doi: 10.1152/jappl.1980.49.5.809. [DOI] [PubMed] [Google Scholar]
  14. Ewing D. J., Neilson J. M., Shapiro C. M., Stewart J. A., Reid W. Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J. 1991 May;65(5):239–244. doi: 10.1136/hrt.65.5.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ewing D. J., Neilson J. M., Travis P. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. Br Heart J. 1984 Oct;52(4):396–402. doi: 10.1136/hrt.52.4.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fagraeus L., Linnarsson D. Autonomic origin of heart rate fluctuations at the onset of muscular exercise. J Appl Physiol. 1976 May;40(5):679–682. doi: 10.1152/jappl.1976.40.5.679. [DOI] [PubMed] [Google Scholar]
  17. Francis G. S., Goldsmith S. R., Cohn J. N. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J. 1982 Oct;104(4 Pt 1):725–731. doi: 10.1016/0002-8703(82)90003-5. [DOI] [PubMed] [Google Scholar]
  18. Genest J., Granger P., De Champlain J., Boucher R. Endocrine factors in congestive heart failure. Am J Cardiol. 1968 Jul;22(1):35–42. doi: 10.1016/0002-9149(68)90244-0. [DOI] [PubMed] [Google Scholar]
  19. Ghali J. K., Cooper R., Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern Med. 1990 Apr;150(4):769–773. [PubMed] [Google Scholar]
  20. Goldstein R. E., Beiser G. D., Stampfer M., Epstein S. E. Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res. 1975 May;36(5):571–578. doi: 10.1161/01.res.36.5.571. [DOI] [PubMed] [Google Scholar]
  21. Katona P. G., Jih F. Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J Appl Physiol. 1975 Nov;39(5):801–805. doi: 10.1152/jappl.1975.39.5.801. [DOI] [PubMed] [Google Scholar]
  22. Kleiger R. E., Miller J. P., Bigger J. T., Jr, Moss A. J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987 Feb 1;59(4):256–262. doi: 10.1016/0002-9149(87)90795-8. [DOI] [PubMed] [Google Scholar]
  23. Laragh J. H. Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone. Drugs. 1986;32 (Suppl 5):1–12. doi: 10.2165/00003495-198600325-00002. [DOI] [PubMed] [Google Scholar]
  24. Levine T. B., Francis G. S., Goldsmith S. R., Cohn J. N. The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation. 1983 May;67(5):1070–1075. doi: 10.1161/01.cir.67.5.1070. [DOI] [PubMed] [Google Scholar]
  25. Levine T. B., Francis G. S., Goldsmith S. R., Simon A. B., Cohn J. N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982 May;49(7):1659–1666. doi: 10.1016/0002-9149(82)90243-0. [DOI] [PubMed] [Google Scholar]
  26. Levine T. B., Francis G. S., Goldsmith S. R., Simon A. B., Cohn J. N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982 May;49(7):1659–1666. doi: 10.1016/0002-9149(82)90243-0. [DOI] [PubMed] [Google Scholar]
  27. Lumbers E. R., McCloskey D. I., Potter E. K. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol. 1979 Sep;294:69–80. doi: 10.1113/jphysiol.1979.sp012915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mancia G. Neurohumoral activation in congestive heart failure. Am Heart J. 1990 Dec;120(6 Pt 2):1532–1537. doi: 10.1016/0002-8703(90)90054-2. [DOI] [PubMed] [Google Scholar]
  29. McAreavey D., Neilson J. M., Ewing D. J., Russell D. C. Cardiac parasympathetic activity during the early hours of acute myocardial infarction. Br Heart J. 1989 Sep;62(3):165–170. doi: 10.1136/hrt.62.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Myers G. A., Martin G. J., Magid N. M., Barnett P. S., Schaad J. W., Weiss J. S., Lesch M., Singer D. H. Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE Trans Biomed Eng. 1986 Dec;33(12):1149–1156. doi: 10.1109/TBME.1986.325694. [DOI] [PubMed] [Google Scholar]
  31. Newman T. J., Maskin C. S., Dennick L. G., Meyer J. H., Hallows B. G., Cooper W. H. Effects of captopril on survival in patients with heart failure. Am J Med. 1988 Mar 11;84(3A):140–144. doi: 10.1016/0002-9343(88)90221-5. [DOI] [PubMed] [Google Scholar]
  32. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 1985 Oct;72(4):681–685. doi: 10.1161/01.cir.72.4.681. [DOI] [PubMed] [Google Scholar]
  33. Pomeranz B., Macaulay R. J., Caudill M. A., Kutz I., Adam D., Gordon D., Kilborn K. M., Barger A. C., Shannon D. C., Cohen R. J. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985 Jan;248(1 Pt 2):H151–H153. doi: 10.1152/ajpheart.1985.248.1.H151. [DOI] [PubMed] [Google Scholar]
  34. Potter E. K. Angiotensin inhibits action of vagus nerve at the heart. Br J Pharmacol. 1982 Jan;75(1):9–11. doi: 10.1111/j.1476-5381.1982.tb08752.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Saul J. P., Arai Y., Berger R. D., Lilly L. S., Colucci W. S., Cohen R. J. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol. 1988 Jun 1;61(15):1292–1299. doi: 10.1016/0002-9149(88)91172-1. [DOI] [PubMed] [Google Scholar]
  36. Schwarz F., Mall G., Zebe H., Schmitzer E., Manthey J., Scheurlen H., Kübler W. Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation. 1984 Dec;70(6):923–928. doi: 10.1161/01.cir.70.6.923. [DOI] [PubMed] [Google Scholar]
  37. Thomas J. A., Marks B. H. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978 Feb;41(2):233–243. doi: 10.1016/0002-9149(78)90162-5. [DOI] [PubMed] [Google Scholar]
  38. Unverferth D. V., Magorien R. D., Moeschberger M. L., Baker P. B., Fetters J. K., Leier C. V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984 Jul 1;54(1):147–152. doi: 10.1016/0002-9149(84)90320-5. [DOI] [PubMed] [Google Scholar]
  39. Wathen C. G., Muir A. L., Hannan W. J. Radionuclide studies of left ventricular function in normal subjects. Nucl Med Commun. 1990 Sep;11(9):607–615. doi: 10.1097/00006231-199009000-00004. [DOI] [PubMed] [Google Scholar]
  40. Zelis R., Mason D. T. Compensatory mechanisms in congestive heart failure--the role of the peripheral resistance vessels. N Engl J Med. 1970 Apr 23;282(17):962–964. doi: 10.1056/NEJM197004232821707. [DOI] [PubMed] [Google Scholar]
  41. Zimmerman B. G. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci (Lond) 1981 Apr;60(4):343–348. doi: 10.1042/cs0600343. [DOI] [PubMed] [Google Scholar]
  42. Zuanetti G., Latini R., Neilson J. M., Schwartz P. J., Ewing D. J. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol. 1991 Mar 1;17(3):604–612. doi: 10.1016/s0735-1097(10)80172-x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES